<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01182974</url>
  </required_header>
  <id_info>
    <org_study_id>1662CTIL</org_study_id>
    <nct_id>NCT01182974</nct_id>
  </id_info>
  <brief_title>Paracetamol Toxicity in Septic Patients</brief_title>
  <official_title>Paracetamol-induced Liver Toxicity in Septic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barzilai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Barzilai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will examine the toxicity of therapeutic doses of paracetamol in patients
      in severe sepsis. Patients with fever and severe sepsis will be randomized to receive
      paracetamol or dypirone. The investigators will monitor blood glutathione and liver enzymes
      to look for potential toxicity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Paracetamol is metabolized in liver using the glutathione system. This detoxification system
      is depressed during severe illness such as sepsis, trauma etc. The study will examine the
      toxicity of therapeutic doses of paracetamol in patients in severe sepsis. We believe that
      during sepsis, paracetamol metabolites are not fully detoxified and therefore are toxic to
      the patient.

      Patients with fever and severe sepsis will be randomized to receive paracetamol or dypirone.
      The investigators will monitor blood glutathione (as a surrogate marker for liver
      glutathione), liver enzymes and various clinical data (such as length of hospitalization) to
      look for a potential toxicity.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Difficulty in patient enrollment
  </why_stopped>
  <start_date>August 2010</start_date>
  <completion_date type="Anticipated">August 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>paracetamol induced liver toxicity</measure>
    <time_frame>every six months</time_frame>
    <description>defined as ALT and/or AST &gt; 1000 or reduction in glutathione below 50% of base line</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Fever</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>paracetamol treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control- dypirone treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>1 gr of paracetamol PO/PZ/PR</description>
    <arm_group_label>paracetamol treatment</arm_group_label>
    <other_name>acetaminophen, acamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dypirone</intervention_name>
    <description>1 gr PO/PZ/PR/IM</description>
    <arm_group_label>control- dypirone treatment</arm_group_label>
    <other_name>optalgin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18y

          -  hospitalized to int. med. dept. or ICU

          -  body temp&gt;38 and one or more from the following:

               1. pulse&gt;90 bpm

               2. resp. rate&gt;20/min or PaCO2&lt;32 mmHg

               3. WBC&gt;12000 or &lt;4000

          -  one of the following:

               1. hypotension

               2. disturbed end-organ perfusion (confusion, oliguria, lactic acidosis etc.)

        Exclusion Criteria:

          -  acute / chronic liver disease

          -  acute CNS disorder

          -  current isoniazid treatment

          -  alcoholism

          -  active malignancy

          -  pregnancy

          -  TPN or PPN
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert Grinshpun</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barziali medical center, Ashkelon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barzilai medical center</name>
      <address>
        <city>Ashkelon</city>
        <zip>78278</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2010</study_first_submitted>
  <study_first_submitted_qc>August 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2010</study_first_posted>
  <last_update_submitted>March 1, 2011</last_update_submitted>
  <last_update_submitted_qc>March 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Albert Grinshpun</name_title>
    <organization>Barzilai medical center</organization>
  </responsible_party>
  <keyword>fever in severe sepsis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

